Clinical Trial Update: Promising ROd-cone DYstrophy Gene therapY [Phase 1, Phase 2]

View source ↗

Summary

SparingVision reports a Phase 1/2 clinical trial evaluating a rod-cone dystrophy gene therapy for retinitis pigmentosa, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• Rod-cone dystrophy gene therapy

Snippet

Sponsor: SparingVision | Conditions: Retinitis Pigmentosa | Phase 1, Phase 2 | Status: RECRUITING